Literature DB >> 6278682

Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins.

F R Applebaum, J D Meyers, A Fefer, N Fluornoy, M A Cheever, P D Greenberg, R Hackman, E D Thomas.   

Abstract

Pneumonia attributable to causes other than bacterial or fungal infection is a major complication of allogeneic marrow transplantation. In this study, the incidence, mortality, and possible risk factors for the development of nonbacterial, nonfungal pneumonia after 100 syngeneic marrow transplants for hematological malignancy are reviewed and compared with the results found in 351 allogeneic marrow transplants performed during the same time period. Both the incidence and mortality of pneumonia were far lower among syngeneic patients, especially for pneumonia associated with cytomegalovirus. Idiopathic pneumonia, however, occurred with about equal frequency in the two populations. Among twins, an increased incidence of pneumonia was seen in older patients and in those who received chemotherapy in addition to cyclophosphamide and total body irradiation as part of the preparative regimen for transplantation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278682     DOI: 10.1097/00007890-198203000-00011

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  The pulmonary complications of bone marrow transplantation in adults.

Authors:  P W Noble
Journal:  West J Med       Date:  1989-04

2.  Detection of cytomegalovirus antigens and DNA in tissues fixed in formaldehyde.

Authors:  N M Jiwa; A K Raap; F M van de Rijke; A Mulder; J J Weening; F E Zwaan; T H The; M van der Ploeg
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

Review 3.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

4.  Histopathology of the lung after bone marrow transplantation.

Authors:  J P Sloane; M H Depledge; R L Powles; G R Morgenstern; B S Trickey; P J Dady
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

5.  The potential usefulness of interleukin-2 activated bone marrow cells as an active therapeutic tool against cytomegalovirus infection in a bone marrow transplantation setting.

Authors:  R Agah; A Mazumder
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

6.  Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation.

Authors:  C A Müller; H Hebart; A Roos; H Roos; M Steidle; H Einsele
Journal:  Med Microbiol Immunol       Date:  1995-10       Impact factor: 3.402

7.  Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.

Authors:  F S Stals; A Zeytinoglu; M Havenith; E de Clercq; C A Bruggeman
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

8.  Pneumonias in adults due to mycoplasma, chlamydiae, and viruses.

Authors:  J P Luby
Journal:  Am J Med Sci       Date:  1987-07       Impact factor: 2.378

9.  Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Rafaela Holtappels; Sina I Schader; Oliver Oettel; Jürgen Podlech; Christof K Seckert; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Front Cell Infect Microbiol       Date:  2020-04-15       Impact factor: 5.293

10.  Pathogenesis of cytomegalovirus-associated pneumonitis in ICR mice: possible involvement of superoxide radicals.

Authors:  T Ikeda; K Shimokata; T Daikoku; T Fukatsu; Y Tsutsui; Y Nishiyama
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.